Lipoprotein nanoplatform for targeted delivery of diagnostic and therapeutic agents

Molecular Imaging

Volumn 7, Issue 2, 2008, Pages 101-110

  Glickson, Jerry D ^a   Lund Katz, Sissel ^b   Zhou, Rong ^b   Choi, Hoon ^b   Chen, I Wei ^b   Li, Hui ^b   Corbin, Ian ^b   Popov, Anatoliy V ^b   Cao, Weiguo ^b   Song, Liping ^b   Qi, Chenze ^b   Marotta, Diane ^b   Nelson, David S ^b   Chen, Juan ^b   Chance, Britton ^b   Zheng, Gang ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b B6 Blockley Hall ^*

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; CELL TRACKING; CHEMOTHERAPEUTIC AGENTS; CHLORIN; CONTRAST AGENTS; COVALENT ATTACHMENTS; FOLATE RECEPTORS; HELICAL PEPTIDES; HIGH-DENSITY LIPOPROTEINS; IN-SITU LOADINGS; IN-VIVO; IRON OXIDE NANOPARTICLES; LOW-DENSITY LIPOPROTEINS; MAGNETIC RESONANCE IMAGING CONTRAST AGENTS; NATURAL RECEPTORS; NEAR INFRA REDS; NEOPLASTIC CELLS; OPTICAL IMAGING; PHOSPHOLIPID MONOLAYERS; PROTEIN LOADINGS; SIDE CHAINS; SURFACE LOADINGS; TARGETED DELIVERIES; THERAPEUTIC AGENTS; TUMOR CELLS;

AMINES; CELL CULTURE; ESTERS; GADOLINIUM; GENE EXPRESSION; INFRARED DEVICES; IRON OXIDES; MAGNETIC RESONANCE IMAGING; MAGNETITE; NANOPARTICLES; OPTICAL MATERIALS; OXIDE MINERALS; PHOSPHOLIPIDS; PHOTODYNAMIC THERAPY; PLASMONS; PROTEINS; TUMORS;

LOADING;

ANTINEOPLASTIC AGENT; CARRIER PROTEIN; CELL SURFACE RECEPTOR; FOLATE BINDING PROTEIN; FOLATE-BINDING PROTEIN; GADOLINIUM; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DELIVERY SYSTEM; EVALUATION; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MOUSE; NANOTECHNOLOGY; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; PARTICLE SIZE; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; CARRIER PROTEINS; DRUG DELIVERY SYSTEMS; GADOLINIUM; HUMANS; LIPOPROTEINS, LDL; MAGNETIC RESONANCE IMAGING; MICE; MICE, NUDE; MOLECULAR STRUCTURE; NANOTECHNOLOGY; NEOPLASMS; PARTICLE SIZE; RECEPTORS, CELL SURFACE; RECEPTORS, LDL;

EID: 55749088228     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2008.0012     Document Type: Article

References (37)

1. Vance DE, Vance JE. Biochemistry of lipids, lipoproteins and membranes. Amsterdam: Elsevier Science; 2002.
2. Shaw JM. Lipoproteins as carriers of pharmacological agents. New York: Marcel Dekker; 1991.
3. Zheng G, Chen J, Li H, Glickson JD. Rerouting lipoprotein nanopartides to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents. Proc Natl Acad Sd U S A 2005;102:17757-62.
4. Li H, Zhang ZH, Blessington D, et al. Carbocyanine labeled LDL for optical imaging of tumors. Acad Radiol 2004;11:669-77.
5. Zheng G, Li H, Zhang M, et al. Low-density lipoprotein reconstituted by pyropheophorbide cholesteryl oleate as targetspecific photosensitizer. Bioconj Chem 2002;13:392-6.
6. Corbin IR, Li H, Chen J, et al. Low-density lipoprotein nanopartides as magnetic resonance imaging contrast agents. Neoplasia 2006;8:488-98.
7. Brown MS, Goldstein JL. Receptor-mediated endocytosis: Insights from the lipoprotein receptor system. Proceedings of the National Academy of Sciences, USA. 1979;76:3330-7.
8. Firestone RA. Low density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells. Bioconj Chem 1994;5:105-13.
9. de Smidt PC, van Berkel TJC. Prolonged serum half-life of antineoplastic drugs by incorporation into the low density lipoprotein. Cancer Res 1990;50:7476-82.
10. Rensen PCN, Schiffelers RM, Versluis J, et al. Human recombinant apolipoprotein E-enriched liposomes can mimic low-density lipoproteins as carriers for the site-specific delivery of antitumor agents. Mol Pharmacol 1997;52:445-55.
11. Li H, Gray BD, Corbin I, et al. MR and fluorescent imaging of low-density lipoprotein receptors. Acad Radiol 2004;11:1251-9.
12. Moerlein SM, Daugherty A, Sobel BE, Welch MJ. Metabolic imaging with gallium-68-labeled and indium-111-labeled low-density-lipoprotein. J Nucl Med 1991;32:300-7.
13. Ponty E, Favre G, Benaniba R, et al. Biodistribution study of Tc99m-labded Ldl in B16-mdanoma-bearing mice - visualization of a preferential uptake by the tumor. Int J Cancer 1993;54:411-7.
14. Pietzsch J, Bergmann R, Rode K, et al. Fluorine-18 radiolabeling of low-density lipoproteins: a potential approach for characterization and differentiation of metabolism of native and oxidized low-density lipoproteins in vivo. Nucl Med Biol 2004;31:1043-50.
15. Sobal G, Resch U, Sinzinger H. Modification of low-density lipoprotein by different radioiodination methods. Nucl Med Biol 2004;31:381-8.
16. Krieger M, Brown MS, Faust JR, Goldstein JL. Replacement of endogenous cholesteryl esters of low density lipoprotein with exogenous cholesteryl linoleate. Reconstitution of a biologically active lipoprotein partide. J Biol Chem 1978;253:4093-101.
17. Krieger M, Ho YK, Falck JR. Reconstitution of LDL with lipophilic fluorescein derivatives: quantitative analysis of the receptor activity of human lymphocytes. J Receptor Res 1983;3:361-75.
18. Zheng G, Li H, Yang K, et al. Tricarbocyanine cholesteryl laurates labeled LDL: new near infrared fluorescent probes (NIRFs) for monitoring tumors and gene therapy of familial hypercholesterolemia. Bioorg Med Chem Lett 2002;12:1485-8.
19. Wu SP, Lee I, Ghoroghchian PP, et al. Near-infrared optical Imaging of B16 melanoma cells via low-density lipoproteinmediated uptake and delivery of high emission dipole strength tris[(porphinato)zinc(II)] fluorophores. Bioconj Chem 2005;16: 542-50.
20. Quistorff B, Haselgrove JC, Chance B. High resolution readout of 3-D metabolic organ structure: an automated, low-temperature redox ratio-scanning instrument. Anal Biochem 1985;148:389-400.
21. Pandey RK, Goswami LN, Chen Y, et al. Nature: a rich source for developing multifunctional agents. Tumor-imaging and photodynamic therapy. Lasers Surg Med 2006;38:445-67.
22. Pandey RK, Zheng G. Porphyrins as photosensitizers in photodynamic therapy (Chapter 43). In: Kadish K, Smith KM, Guilard R, editors. The porphyrin handbook. San Diego: Academic Press; 2000. p. 157-230.
23. Brandis A, Mazor O, Neumark E, et al. Novel water-soluble bacteriochlorophyll derivatives for vascular-targeted photodynamic therapy: synthesis, solubility, phototoxicity and the effect of serum proteins. Photochem Photobiol 2005;81:983-93.
24. Li H, Marotta DE, Kim S, et al. High payload delivery of optical imaging and photodynamic therapy agents to tumors using phthalocyanine-reconstituted low-density lipoprotein nanopartides. J Biomed Opt 2005; 10.
25. Lund-Katz S, Ibdah JA, Letizia JY, et al. A 13C NMR characterization of lysine residues in apolipoprotein B and their role in binding to the low density lipoprotein receptor. J Biol Chem 1988;263:13831-8.
26. Chen J, Corbin IR, Li H, et al. Ligand conjugated low-density lipoprotein nanopartides for enhanced optical cancer imaging in vivo. J Am Chem Soc 2007;129:5798-9.
27. Corbin IR, Chen J, Cao W, et al. Enhanced cancer-targeted delivery using engineered high-density lipoprotein-based nanocarriers. J Biomed. Nanotech 2007;3:367-76.
28. Mulder WJM, Griffioen AW, Strijkers GJ, et al. Magnetic and fluorescent nanopartides for multimodality imaging. Nanomedicine 2007;2:307-24.
29. Fayad ZA, Fuster V. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ Res 2001;89:305-16.
30. Wisner ER, Weichert JP, Longino MA, et al. A surface-modified chylomicron remnant-like emulsion for percutaneous computed tomography lymphography - synthesis and preliminary imaging findings. Invest Radiol 2002;37:232-9.
31. Bulte JWM, Arbab AS, Douglas T, Frank JA. Preparation of magnetically labeled cells for cell tracking by magnetic resonance imaging. Imaging in Biological Research, Pt B, 2004;386:275-99.
32. Hinds KA, Hill JM, Shapiro EM, et al. Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood 2003; 102: 867-72.
33. Bulte JWM, Duncan ID, Frank JA. In vivo magnetic resonance tracking of magnetically labeled cells after transplantation. J Cereb Blood Flow Metab 2002;22:899-907.
34. Weissleder R, Mahmood U. Molecular imaging. Radiology 2001; 219:316-33.
35. WeisslederR, BogdanovA, Neuwelt EA, PapisovM. Long-drculating iron-oxides for MR-imaging. Adv Drug Deliv Rev 1995;16:321-34.
36. Choi H, Choi SR, Zhou R, et al. Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery. Acad Radiol 2004;11:996-1004.
37. Navab M, Anantharamaiah GM, Reddy ST, et al. Apolipoprotein A-I mimetic peptides. Arterioscler Thromb Vasc Biol 2005;25:1325-31.